Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Crosstalk within GPCR heteromers in schizophrenia and Parkinson's disease: physical or just functional?

Guixa-Gonzalez R, Bruno A, Marti-Solano M, Selent J.

Curr Med Chem. 2012;19(8):1119-34. doi: 10.2174/092986712799320574.

Automated method to distinguish toe walking strides from normal strides in the gait of idiopathic toe walking children from heel accelerometry data

Pendharkar G, Percival P, Morgan D, Lai D.

Gait Posture. 2012 Mar;35(3):478-82. doi: 10.1016/j.gaitpost.2011.11.011. Epub 2012 Jan 31.

Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies

El Khoury MA, Gorgievski V, Moutsimilli L, Giros B, Tzavara ET.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):36-50. doi: 10.1016/j.pnpbp.2011.12.005. Epub 2012 Jan 20.

Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease

Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W.

Neurodegener Dis. 2012;10(1-4):212-5. doi: 10.1159/000334536. Epub 2012 Feb 1.

Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease

Oueslati A, Paleologou KE, Schneider BL, Aebischer P, Lashuel HA.

J Neurosci. 2012 Feb 1;32(5):1536-44. doi: 10.1523/JNEUROSCI.3784-11.2012.

Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice

Jang H, Boltz D, McClaren J, Pani AK, Smeyne M, Korff A, Webster R, Smeyne RJ.

J Neurosci. 2012 Feb 1;32(5):1545-59. doi: 10.1523/JNEUROSCI.5123-11.2012.

LRRK2 inhibition attenuates microglial inflammatory responses

Moehle MS, Webber PJ, Tse T, Sukar N, Standaert DG, DeSilva TM, Cowell RM, West AB.

J Neurosci. 2012 Feb 1;32(5):1602-11. doi: 10.1523/JNEUROSCI.5601-11.2012.

Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma

Fang J, Jiang F, Li J, Zhu Y.

Neural Regen Res. 2012 Feb 5;7(4):313-8. doi: 10.3969/j.issn.1673-5374.2012.04.013.

3-(4-[(18)F]Fluorobenzyl)-8-methoxy-1,2,3,4 tetrahydrochromeno[3,4-c]pyridin-5-one

Leung K.

2005 Dec 5 [updated 2012 Feb 7]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline

Zagmutt FJ, Tarrants ML.

Int J Neurosci. 2012 Jul;122(7):345-53. doi: 10.3109/00207454.2012.660586. Epub 2012 Mar 23.

Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature

Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G.

J Sex Med. 2012 Apr;9(4):970-85. doi: 10.1111/j.1743-6109.2011.02615.x. Epub 2012 Feb 3.

[Transcient improvement of extrapyramidal syndrome after general anaesthesia]

Poivert C, Graftieaux JP, Gomis P, Scherpereel B, Malinovsky JM.

Ann Fr Anesth Reanim. 2012 Mar;31(3):251-4. doi: 10.1016/j.annfar.2011.12.003. Epub 2012 Feb 3.

Effects of natural antioxidants in neurodegenerative disease

Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L, Barreto GE.

Nutr Neurosci. 2012 Jan;15(1):1-9. doi: 10.1179/1476830511Y.0000000028.

Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review

Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A.

Neurosci Biobehav Rev. 2012 Apr;36(4):1140-52. doi: 10.1016/j.neubiorev.2012.01.004. Epub 2012 Jan 28.

Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?

Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V.

Neurochem Int. 2012 Sep;61(4):559-65. doi: 10.1016/j.neuint.2012.01.017. Epub 2012 Jan 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias